Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cuaresma RA"'
Autor:
Blume JE; Seer, Inc., Redwood City, CA, 94065, USA. jblume@seer.bio., Manning WC; Seer, Inc., Redwood City, CA, 94065, USA., Troiano G; Seer, Inc., Redwood City, CA, 94065, USA., Hornburg D; Seer, Inc., Redwood City, CA, 94065, USA., Figa M; Seer, Inc., Redwood City, CA, 94065, USA., Hesterberg L; Seer, Inc., Redwood City, CA, 94065, USA., Platt TL; Seer, Inc., Redwood City, CA, 94065, USA., Zhao X; Seer, Inc., Redwood City, CA, 94065, USA., Cuaresma RA; Seer, Inc., Redwood City, CA, 94065, USA., Everley PA; Seer, Inc., Redwood City, CA, 94065, USA., Ko M; Seer, Inc., Redwood City, CA, 94065, USA., Liou H; Seer, Inc., Redwood City, CA, 94065, USA., Mahoney M; Seer, Inc., Redwood City, CA, 94065, USA., Ferdosi S; Seer, Inc., Redwood City, CA, 94065, USA., Elgierari EM; Seer, Inc., Redwood City, CA, 94065, USA., Stolarczyk C; Seer, Inc., Redwood City, CA, 94065, USA., Tangeysh B; Seer, Inc., Redwood City, CA, 94065, USA., Xia H; Seer, Inc., Redwood City, CA, 94065, USA., Benz R; Seer, Inc., Redwood City, CA, 94065, USA., Siddiqui A; Seer, Inc., Redwood City, CA, 94065, USA., Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA., Ma P; Seer, Inc., Redwood City, CA, 94065, USA., Langer R; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Farias V; Sloan School and Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. vivekf@mit.edu., Farokhzad OC; Seer, Inc., Redwood City, CA, 94065, USA. ofarokhzad@bwh.harvard.edu.; Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. ofarokhzad@bwh.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2020 Jul 22; Vol. 11 (1), pp. 3662. Date of Electronic Publication: 2020 Jul 22.
Autor:
Lin, Mengna, Xu, Feixiang, Sun, Jian, Song, Jianfeng, Shen, Yao, Lu, Su, Ding, Hailin, Lan, Lulu, Chen, Chen, Ma, Wen, Wu, Xueling, Song, Zhenju, Wang, Weibing
Publikováno v:
Critical Care; 7/2/2024, Vol. 28 Issue 1, p1-16, 16p
Autor:
Wang, Xiaoke1 (AUTHOR), Wu, Tong2 (AUTHOR), Yang, Yingxin3 (AUTHOR), Zhou, Long3 (AUTHOR), Wang, Shuxian3 (AUTHOR), Liu, Jiaxing4 (AUTHOR), Zhao, Yafang3 (AUTHOR), Zhang, Meiling5 (AUTHOR), Zhao, Yan3 (AUTHOR), Qu, Huihua3,6 (AUTHOR) quhuihuadr@163.com, Kong, Hui3 (AUTHOR) doris7629@126.com, Zhang, Yue7 (AUTHOR) 201801024@bucm.edu.cn
Publikováno v:
Journal of Nanobiotechnology. 2/23/2023, Vol. 21 Issue 1, p1-16. 16p.
Autor:
Ye, Xueting1,2,3 (AUTHOR), Cui, Xiaozhen3 (AUTHOR), Zhang, Luobin1 (AUTHOR), Wu, Qiong3 (AUTHOR), Sui, Xintong3 (AUTHOR), He, An3 (AUTHOR), Zhang, Xinyou1 (AUTHOR) zhangxinyou0518@sina.com, Xu, Ruilian1 (AUTHOR) xuruilian@126.com, Tian, Ruijun3 (AUTHOR) tianrj@sustech.edu.cn
Publikováno v:
Clinical Proteomics. 1/7/2023, p1-10. 10p.
Publikováno v:
Indian Journal of Biochemistry & Biophysics. Apr2022, Vol. 59 Issue 4, p405-414. 10p.
Autor:
Sazawal, Sunil1 ssazawal@jhu.edu, Ryckman, Kelli K.2, Das, Sayan1, Khanam, Rasheda3, Nisar, Imran4, Jasper, Elizabeth2, Dutta, Arup1, Rahman, Sayedur5, Mehmood, Usma4, Bedell, Bruce2, Deb, Saikat6, Chowdhury, Nabidul Haque5, Barkat, Amina4, Mittal, Harshita1, Ahmed, Salahuddin5, Khalid, Farah4, Raqib, Rubhana7, Manu, Alexander8, Yoshida, Sachiyo8, Ilyas, Muhammad4
Publikováno v:
BMC Pregnancy & Childbirth. 9/7/2021, Vol. 21 Issue 1, p1-11. 11p.
Publikováno v:
American Journal of Physiology: Heart & Circulatory Physiology; Nov2023, Vol. 325 Issue 5, p1039-1058, 20p
Publikováno v:
Journal of Plant Growth Regulation; Oct2023, Vol. 42 Issue 10, p6377-6396, 20p
This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicin
Autor:
Masakazu Toi
This book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathologica